>>44
ïŒã¯ã¯ãã³ã«ãã£ãŠã³ããæ»ãé²ãããšããããŒã¿åºã
èšåºè©Šéšçµæã§ã¯ã ãã§ããïŒ
ã¯ã¯ãã³ïŒåæ¥çš®ããïŒæ¥çµé以éã¯ããã©ã»ã矀ãšæ¯èŒãããšçºçäºé²å¹æãèªããããïŒã¯ã¯ãã³æ¥çš®ã§COVID-19ãçºçãã確çãäœæžã§ããã®ã§ãæ»ã«ã«ãããªã£ãŠããïŒã³ããæ»ãé²ããïŒ
âãã¡ã€ã¶ãŒè£œæ°åã³ããã¯ã¯ãã³ïŒBNT162b2ïŒå¯©è°çµæå ±åæž
www.pmda.go.jp/drugs/2021/P20210212001/672212000_30300AMX00231_A100_6.pdf
ã»æµ·å€èšåºè©ŠéšïŒC4591001 è©ŠéšïŒâ
/â
¡/â
¢çžè©Šéšå®æœ
ã第â
çžããŒãïŒå®å
šæ§ãå¿å®¹æ§ã確èª
ã第â
¡/â
¢çžããŒãïŒæå¹æ§ãå®å
šæ§ã確èª
ã»æ¥æ¬åœå
èšåºè©ŠéšïŒC4591005 è©ŠéšïŒâ
/â
¡çžè©Šéšå®æœ
ãå®å
šæ§ãå¿å®¹æ§ãå
ç«åæ§ã確èª
âã¢ãã«ã補æ°åã³ããã¯ã¯ãã³ïŒmRNA-1273ïŒå¯©è°çµæå ±åæžã
www.pmda.go.jp/drugs/2021/P20210519003/400256000_30300AMX00266_A100_4.pdf
ã»æµ·å€èšåºè©Šéšã
ã第â
çžè©ŠéšïŒ20-0003 è©ŠéšïŒïŒå®å
šæ§ãå
ç«åæ§ã確èª
ã第â
¡a çžè©ŠéšïŒmRNA-1273-P201 è©ŠéšïŒïŒå®å
šæ§ãå
ç«åæ§ã確èª
ã第â
¢çžè©ŠéšïŒmRNA-1273-P301 è©ŠéšïŒïŒæå¹æ§ãå®å
šæ§ãå
ç«åæ§ã確èª
ã»æ¥æ¬åœå
èšåºè©ŠéšïŒTAK-919-1501 è©ŠéšïŒâ
/â
¡çžè©Šéšå®æœ
ãå®å
šæ§ãå
ç«åæ§ã確èª